unknown
Stage
1
Investors
About
Geneoscopy develops noninvasive stool-based molecular diagnostic tests using RNA technology for colorectal cancer screening and gastrointestinal disease management.
Explore Geneoscopy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.